Boehringer Ingelheim Pharmaceuticals
Boehringer Ingelheim Pharmaceuticals, Inc.
900 Ridgebury Road
Ridgefield, CT 06877
Phone: (800) 243-0127Website: https://www.boehringer-ingelheim.us/Careers: www.boehringer-ingelheim.us/careersPatient Assistance Program: www.boehringer-ingelheim.us...
Latest news
- FDA Approves Expanded Generalized Pustular Psoriasis Indications for Spevigo
19 March 2024 - US FDA Approves Jardiance for the Treatment of Adults with Chronic Kidney Disease
22 September 2023 - FDA Approves Jardiance (empagliflozin) for the Treatment of Type 2 Diabetes in Children 10 Years and Older
21 June 2023 - US FDA Approves the Cyltezo Pen, a New Autoinjector Option, Ahead of July 1 Commercial Launch
22 May 2023 - EMPA-KIDNEY trial showed significant benefit of Jardiance in reducing kidney disease progression or cardiovascular death in people with chronic kidney disease
4 November 2022 - FDA Approves Spevigo (spesolimab-sbzo) for Generalized Pustular Psoriasis (GPP) Flares in Adults
3 September 2022 - New Spesolimab Data Showed Significant Improvement in Patients with Generalized Pustular Psoriasis (GPP) Flares
28 March 2022 - US FDA Approves Jardiance (empagliflozin) to Treat Adults with Heart Failure Regardless of Left Ventricular Ejection Fraction
25 February 2022 - Newly Published Results Showed Spesolimab Significantly Improved Signs and Symptoms of Flares in Rare, Life-Threatening Skin Disease, Generalized Pustular Psoriasis
23 December 2021 - U.S. FDA Grants Priority Review for Spesolimab for the Treatment of Flares in Patients with Generalized Pustular Psoriasis (GPP)
15 December 2021
Drugs Associated with Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 36 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
Brand/Generic Name | Reviews | Rating |
---|---|---|
Aggrenox
Generic name: aspirin/dipyridamole Drug class: platelet aggregation inhibitors |
17 reviews | 7.1 / 10 |
Aptivus
Generic name: tipranavir Drug class: protease inhibitors |
||
Atrovent HFA
Generic name: ipratropium Drug class: anticholinergic bronchodilators |
3 reviews | 8.7 / 10 |
Atrovent Nasal
Generic name: ipratropium Drug class: nasal antihistamines and decongestants |
2 reviews | 10 / 10 |
Basaglar
Generic name: insulin glargine Drug class: insulin |
129 reviews | 2.5 / 10 |
Catapres
Generic name: clonidine Drug class: antiadrenergic agents, centrally acting |
48 reviews | 7.9 / 10 |
Catapres-TTS
Generic name: clonidine Drug class: antiadrenergic agents, centrally acting |
10 reviews | 8.1 / 10 |
Combivent Respimat
Generic name: albuterol/ipratropium Drug class: bronchodilator combinations |
17 reviews | 3.9 / 10 |
Cyltezo
Generic name: adalimumab Drug class: TNF alfa inhibitors |
||
Duo Fusion
Generic name: calcium carbonate/famotidine/magnesium hydroxide Drug class: H2 antagonists |
||
Flomax
Generic name: tamsulosin Drug class: alpha-adrenoreceptor antagonists |
271 reviews | 5.9 / 10 |
Gilotrif
Generic name: afatinib Drug class: multikinase inhibitors |
1 review | 10 / 10 |
Glyxambi
Generic name: empagliflozin/linagliptin Drug class: antidiabetic combinations |
19 reviews | 6.5 / 10 |
Jardiance
Generic name: empagliflozin Drug class: SGLT-2 inhibitors |
297 reviews | 5.3 / 10 |
Jentadueto
Generic name: linagliptin/metformin Drug class: antidiabetic combinations |
14 reviews | 6.0 / 10 |
Jentadueto XR
Generic name: linagliptin/metformin Drug class: antidiabetic combinations |
2 reviews | 9.0 / 10 |
Micardis
Generic name: telmisartan Drug class: angiotensin receptor blockers |
37 reviews | 5.9 / 10 |
Micardis HCT
Generic name: hydrochlorothiazide/telmisartan Drug class: angiotensin II inhibitors with thiazides |
13 reviews | 7.1 / 10 |
Mirapex ER
Generic name: pramipexole Drug class: dopaminergic antiparkinsonism agents |
6 reviews | 8.8 / 10 |
Mobic
Generic name: meloxicam Drug class: Nonsteroidal anti-inflammatory drugs |
126 reviews | 7.4 / 10 |
Ofev
Generic name: nintedanib Drug class: multikinase inhibitors |
13 reviews | 7.5 / 10 |
Persantine
Generic name: dipyridamole Drug class: cardiac stressing agents, platelet aggregation inhibitors |
||
Pradaxa
Generic name: dabigatran Drug class: thrombin inhibitors |
91 reviews | 7.1 / 10 |
Praxbind
Generic name: idarucizumab Drug class: anticoagulant reversal agents |
||
Spevigo
Generic name: spesolimab Drug class: interleukin inhibitors |
||
Spiriva
Generic name: tiotropium Drug class: anticholinergic bronchodilators |
104 reviews | 5.7 / 10 |
Spiriva Respimat
Generic name: tiotropium Drug class: anticholinergic bronchodilators |
29 reviews | 5.4 / 10 |
Stiolto Respimat
Generic name: olodaterol/tiotropium Drug class: bronchodilator combinations |
42 reviews | 7.1 / 10 |
Striverdi Respimat
Generic name: olodaterol Drug class: adrenergic bronchodilators |
5 reviews | 4.6 / 10 |
Synjardy
Generic name: empagliflozin/metformin Drug class: antidiabetic combinations |
23 reviews | 6.4 / 10 |
Synjardy XR
Generic name: empagliflozin/metformin Drug class: antidiabetic combinations |
10 reviews | 5.1 / 10 |
Tradjenta
Generic name: linagliptin Drug class: dipeptidyl peptidase 4 inhibitors |
67 reviews | 3.3 / 10 |
Trijardy XR
Generic name: empagliflozin/linagliptin/metformin Drug class: antidiabetic combinations |
||
Twynsta
Generic name: amlodipine/telmisartan Drug class: angiotensin II inhibitors with calcium channel blockers |
12 reviews | 8.3 / 10 |
Viramune
Generic name: nevirapine Drug class: NNRTIs |
2 reviews | 4.5 / 10 |
Viramune XR
Generic name: nevirapine Drug class: NNRTIs |
||
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |
Discontinued Drugs
Brand/Generic Name | Reviews | Rating |
---|---|---|
Mirapex
Generic name: pramipexole Drug class: dopaminergic antiparkinsonism agents |
116 reviews | 7.2 / 10 |
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |